FeedLearnCommunityToolsVideo
peppersite
AuditsKnowledgeLearnForumVideoBench toolsCompliance
⌘K
Sign in
Reading the Claim/Module 3

Read a compound entry

Find mechanism, monitoring and who-should-avoid without taking the summary on faith.

Every entry has the same skeleton, and the order is not decorative. Identity first (what the molecule is), then mechanism (what it is proposed to do), then what the evidence actually covers, then monitoring and who should avoid it. A seller’s page runs that sequence backwards: benefit first, identity in the small print.

Read the who should avoid and monitoring sections before the mechanism. They are the parts a marketing page has no reason to write, so they are the fastest test of whether a reference is a reference.

Open alongside
BPC-157
Knowledge check

Answer before you look

These come from the entry’s own reference bank. Nothing is scored — the point is finding the gap between what you assumed and what the entry says.

What is BPC-157?
What does BPC-157 do?
Is BPC-157 FDA-approved?
Why is BPC-157 banned by WADA?

Sign in to keep your progress. The material stays open either way.

Next: The bench math →
peppersite

A centralised hub for research peptides: audits, knowledge, discussion, video, and bench tools. Claims, checked against the paper.

Sections
AuditsKnowledgeForumVideo
Reference
CompoundsReconstitutionDosing referenceSaved
About
ComplianceCorrections logIdentity

Research use only · not for human consumption of any kind